Global Drugs for Schistosomiasis Market Study 2016-2026, by Segment (Praziquantel, Oxamniquine, … …), by Market (S. haematobium, S. mansoni, … …), by Company (Merck, Shin Poong, … …)

Published by 99Strategy on 17th November 2019 | Ref: 1463717 | This Product Is In Stock

$1800 | Single User
$3600 | Site License
$3600 | Enterprise License
$1800 | Single User
$3600 | Site License
$3600 | Enterprise License



Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

The global Drugs for Schistosomiasis market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):




Demand Coverage (Market Size & Forecast, Consumer Distribution):

S. haematobium

S. mansoni

S. japonicum

S. mekongi

S. intercalatum

Company Coverage (Sales data, Main Products & Services etc.):


Shin Poong



Chandra Bhagat Pharma

Taj Pharmaceuticals

Major Region Market

North America



South America

Middle East & Africa

Table of Contents

Table of Content

1 Industry Overview

1.1 Drugs for Schistosomiasis Industry

1.2 Market Segment

1.3 Price & Cost Overview

2 Drugs for Schistosomiasis Market by Type

2.1 By Type

2.2 Market Size by Type

2.3 Market Forecast by Type

3 Global Market Demand

3.1 Segment Overview

3.2 Market Size by Demand

3.3 Market Forecast by Demand

4 Major Region Market

4.1 Global Market Overview

4.2 Major Region

5 Major Companies List

5.1 Merck (Company Profile, Sales Data etc.)

5.2 Shin Poong (Company Profile, Sales Data etc.)

5.3 Bayer (Company Profile, Sales Data etc.)

5.4 EIPICO (Company Profile, Sales Data etc.)

5.5 Chandra Bhagat Pharma (Company Profile, Sales Data etc.)

5.6 Taj Pharmaceuticals (Company Profile, Sales Data etc.)

6 Conclusion

Additional Details



Publisher Information


1463717 | 99SGL180Lif201909000024381

Number of Pages


Report Format


Related Reports

Date Published
Price From

Published by BuddeComm

$3,950 USD

This report is published by 99Strategy

99Strategy is a well-known independent third party market research consulting company in China.

We are committed to providing professional solutions for corporate strategic decision-making, we operate three business department of market research, custom survey and Investment & financing, mainly covering research report, market survey, competitive survey, market channel investigation, market entry research, consumer research, global market research, business Plan, project feasibility study, PPP project consulting, enterprise IPO and equity investment research, special market solutions, industry plan consulting, company strategic planning, sales consulting, management consulting and other services.

Download Free Report Summary PDF

Global Drugs for Schistosomiasis Market Study 2016-2026, by Segment (Praziquantel, Oxamniquine, … …), by Market (S. haematobium, S. mansoni, … …), by Company (Merck, Shin Poong, … …) | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types


Buy now using our secure payment system.